Winogrodzka A[au] - Search Results

Year	Number of Results
1973	2
1997	4
1998	3
1999	3
2000	1
2001	3
2003	1
2005	3
2007	1
2008	3
2009	2
2010	1
2011	3
2013	2
2022	1
2023	0

1

Pharmacological treatment of apathy in neurodegenerative diseases: a systematic review.

Drijgers RL, Aalten P, Winogrodzka A, Verhey FR, Leentjens AF. Drijgers RL, et al. Among authors: winogrodzka a. Dement Geriatr Cogn Disord. 2009;28(1):13-22. doi: 10.1159/000228840. Epub 2009 Jul 17. Dement Geriatr Cogn Disord. 2009. PMID: 19609082 Free article. Review.

2

Preclinical (premotor) Parkinson's disease.

Wolters EC, Francot C, Bergmans P, Winogrodzka A, Booij J, Berendse HW, Stoof JC. Wolters EC, et al. Among authors: winogrodzka a. J Neurol. 2000 Apr;247 Suppl 2:II103-9. J Neurol. 2000. PMID: 10991655 Review.

3

Parkinson's disease, levodopa-use and the risk of melanoma.

Vermeij JD, Winogrodzka A, Trip J, Weber WE. Vermeij JD, et al. Among authors: winogrodzka a. Parkinsonism Relat Disord. 2009 Sep;15(8):551-3. doi: 10.1016/j.parkreldis.2009.05.002. Epub 2009 Jun 5. Parkinsonism Relat Disord. 2009. PMID: 19501540 Review.

4

IBZM- and CIT-SPECT of the dopaminergic system in parkinsonism.

Tissingh G, Booij J, Winogrodzka A, van Royen EA, Wolters EC. Tissingh G, et al. Among authors: winogrodzka a. J Neural Transm Suppl. 1997;50:31-7. doi: 10.1007/978-3-7091-6842-4_4. J Neural Transm Suppl. 1997. PMID: 9120422 Review.

5

Clinical problems in the hospitalized Parkinson's disease patient: systematic review.

Gerlach OH, Winogrodzka A, Weber WE. Gerlach OH, et al. Among authors: winogrodzka a. Mov Disord. 2011 Feb 1;26(2):197-208. doi: 10.1002/mds.23449. Epub 2011 Jan 31. Mov Disord. 2011. PMID: 21284037 Free PMC article. Review.

6

Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy.

Stoof JC, Winogrodzka A, van Muiswinkel FL, Wolters EC, Voorn P, Groenewegen HJ, Booij J, Drukarch B. Stoof JC, et al. Among authors: winogrodzka a. Eur J Pharmacol. 1999 Jun 30;375(1-3):75-86. doi: 10.1016/s0014-2999(99)00260-5. Eur J Pharmacol. 1999. PMID: 10443566 Review.

7

Impulse control and related disorders in Parkinson's disease patients treated with bilateral subthalamic nucleus stimulation: a review.

Broen M, Duits A, Visser-Vandewalle V, Temel Y, Winogrodzka A. Broen M, et al. Among authors: winogrodzka a. Parkinsonism Relat Disord. 2011 Jul;17(6):413-7. doi: 10.1016/j.parkreldis.2011.02.013. Epub 2011 Mar 5. Parkinsonism Relat Disord. 2011. PMID: 21382739 Review.

8

Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism.

Booij J, Tissingh G, Winogrodzka A, van Royen EA. Booij J, et al. Among authors: winogrodzka a. Eur J Nucl Med. 1999 Feb;26(2):171-82. doi: 10.1007/s002590050374. Eur J Nucl Med. 1999. PMID: 9933352 Review.

9

Winogrodzka A, Booij J, Wolters ECh. Winogrodzka A, et al. Parkinsonism Relat Disord. 2005 Dec;11(8):475-84. doi: 10.1016/j.parkreldis.2005.08.001. Epub 2005 Oct 27. Parkinsonism Relat Disord. 2005. PMID: 16257254 Review.

10

Comparison of [¹⁸F]-FDOPA PET and [¹²³I]-FP-CIT SPECT acquired in clinical practice for assessing nigrostriatal degeneration in patients with a clinically uncertain parkinsonian syndrome.

Wallert E, Letort E, van der Zant F, Winogrodzka A, Berendse H, Beudel M, de Bie R, Booij J, Raijmakers P, van de Giessen E. Wallert E, et al. Among authors: winogrodzka a. EJNMMI Res. 2022 Oct 22;12(1):68. doi: 10.1186/s13550-022-00943-6. EJNMMI Res. 2022. PMID: 36273088 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results